Reduction in microalbuminuria by calcium channel blockers in patients with type 2 diabetes mellitus and hypertension —A randomized, open‐label, active‐controlled, superiority, parallel‐group clinical trial

ConclusionsCilnidipine did not show any additional anti‐albuminuric effect compared with amlodipine in patients with T2D and microalbuminuria treated with an RAS blocker. However, the anti‐albuminuric effect of cilnidipine might differ according to the duration of diabetes.

Source: International Journal of Clinical Practice - August 1, 2017 Category: Internal Medicine Authors: You ‐Cheol Hwang, Kun‐Ho Yoon, Bong‐Soo Cha, Kwan‐Woo Lee, Hak Chul Jang, Kyung Wan Min, Choon Hee Chung, Moon‐Kyu Lee Tags: ORIGINAL PAPER Source Type: research